These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29540538)

  • 1. A77 1726 (leflunomide) blocks and reverses cardiac hypertrophy and fibrosis in mice.
    Ma ZG; Zhang X; Yuan YP; Jin YG; Li N; Kong CY; Song P; Tang QZ
    Clin Sci (Lond); 2018 Mar; 132(6):685-699. PubMed ID: 29540538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
    Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y
    Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
    Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
    Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Roles of Interferon-γ in Cardiac Hypertrophy Induced by Sustained Pressure Overload.
    Kimura A; Ishida Y; Furuta M; Nosaka M; Kuninaka Y; Taruya A; Mukaida N; Kondo T
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29555642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cathelicidin-related antimicrobial peptide suppresses cardiac hypertrophy induced by pressure overload by regulating IGFR1/PI3K/AKT and TLR9/AMPKα.
    Wang X; Chen L; Zhao X; Xiao L; Yi S; Kong Y; Jiang Y; Zhang J
    Cell Death Dis; 2020 Feb; 11(2):96. PubMed ID: 32029708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperine Attenuates Pathological Cardiac Fibrosis Via PPAR-γ/AKT Pathways.
    Ma ZG; Yuan YP; Zhang X; Xu SC; Wang SS; Tang QZ
    EBioMedicine; 2017 Apr; 18():179-187. PubMed ID: 28330809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant effects of hydrogen sulfide on left ventricular remodeling in smoking rats are mediated via PI3K/Akt-dependent activation of Nrf2.
    Zhou X; Zhao L; Mao J; Huang J; Chen J
    Toxicol Sci; 2015 Mar; 144(1):197-203. PubMed ID: 25516494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xanthohumol attenuates isoprenaline-induced cardiac hypertrophy and fibrosis through regulating PTEN/AKT/mTOR pathway.
    Sun TL; Li WQ; Tong XL; Liu XY; Zhou WH
    Eur J Pharmacol; 2021 Jan; 891():173690. PubMed ID: 33127362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Disintegrin and Metalloprotease-22 Attenuates Hypertrophic Remodeling in Mice Through Inhibition of the Protein Kinase B Signaling Pathway.
    Ren L; Wu C; Yang K; Chen S; Ye P; Wu J; Zhang A; Huang X; Wang K; Deng P; Ding X; Chen M; Xia J
    J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29358191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin B deficiency attenuates cardiac remodeling in response to pressure overload via TNF-α/ASK1/JNK pathway.
    Wu QQ; Xu M; Yuan Y; Li FF; Yang Z; Liu Y; Zhou MQ; Bian ZY; Deng W; Gao L; Li H; Tang QZ
    Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1143-54. PubMed ID: 25713304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway.
    Wang X; Liu Y; Xiao L; Li L; Zhao X; Yang L; Chen N; Gao L; Zhang J
    Cell Physiol Biochem; 2018; 51(2):827-841. PubMed ID: 30466089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway.
    Xu M; Xue RQ; Lu Y; Yong SY; Wu Q; Cui YL; Zuo XT; Yu XJ; Zhao M; Zang WJ
    Cardiovasc Res; 2019 Mar; 115(3):530-545. PubMed ID: 30165480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
    Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling.
    Li Y; Li Z; Zhang C; Li P; Wu Y; Wang C; Bond Lau W; Ma XL; Du J
    Circulation; 2017 May; 135(21):2041-2057. PubMed ID: 28249877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous supplement of glucagon like peptide-1 protects the heart against aortic banding induced myocardial fibrosis and dysfunction through inhibiting mTOR/p70S6K signaling and promoting autophagy.
    Zheng RH; Zhang WW; Ji YN; Bai XJ; Yan CP; Wang J; Bai F; Zhao ZQ
    Eur J Pharmacol; 2020 Sep; 883():173318. PubMed ID: 32621911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the Amino Acid Response Pathway Blunts the Effects of Cardiac Stress.
    Qin P; Arabacilar P; Bernard RE; Bao W; Olzinski AR; Guo Y; Lal H; Eisennagel SH; Platchek MC; Xie W; Del Rosario J; Nayal M; Lu Q; Roethke T; Schnackenberg CG; Wright F; Quaile MP; Halsey WS; Hughes AM; Sathe GM; Livi GP; Kirkpatrick RB; Qu XA; Rajpal DK; Faelth Savitski M; Bantscheff M; Joberty G; Bergamini G; Force TL; Gatto GJ; Hu E; Willette RN
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28487390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quercetin Prevents In Vivo and In Vitro Myocardial Hypertrophy Through the Proteasome-GSK-3 Pathway.
    Chen K; Rekep M; Wei W; Wu Q; Xue Q; Li S; Tian J; Yi Q; Zhang G; Zhang G; Xiao Q; Luo J; Liu Y
    Cardiovasc Drugs Ther; 2018 Feb; 32(1):5-21. PubMed ID: 29435775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.
    Wu MP; Zhang YS; Xu X; Zhou Q; Li JD; Yan C
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):157-166. PubMed ID: 28321644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxyl-Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway.
    Liu X; Yang Q; Zhu LH; Liu J; Deng KQ; Zhu XY; Liu Y; Gong J; Zhang P; Li S; Xia H; She ZG
    J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29945911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.
    Valiente-Alandi I; Potter SJ; Salvador AM; Schafer AE; Schips T; Carrillo-Salinas F; Gibson AM; Nieman ML; Perkins C; Sargent MA; Huo J; Lorenz JN; DeFalco T; Molkentin JD; Alcaide P; Blaxall BC
    Circulation; 2018 Sep; 138(12):1236-1252. PubMed ID: 29653926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.